Zobrazeno 1 - 10
of 13
pro vyhledávání: '"R Q Warren"'
Autor:
Ronald C. Kennedy, S P Blatt, M B Bouzas, Gregory P. Melcher, S A Anderson, M T Wong, Zapiola I, Muchinik G, R Q Warren
Publikováno v:
Clinical and diagnostic laboratory immunology. 2(4)
These studies were undertaken to examine whether the presence of human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies in sera of infected individuals would alter the rate of disease progression. HIV-1-infected individuals (n = 87) were
Autor:
M T Wong, R Q Warren, Muchinik G, Cahn P, M B Bouzas, Gregory P. Melcher, Zapiola I, S A Anderson, S P Blatt, H Perez
Utilizing peptides based on the V3 region of gp120, we undertook a serologic examination of human immunodeficiency virus type 1 (HIV-1)-infected individuals from Argentina to determine if prevalent HIV-1 isolates could be identified in this populatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8befa7ee2c9dad1d755611941c4e74a6
https://europepmc.org/articles/PMC227971/
https://europepmc.org/articles/PMC227971/
Autor:
Gregory P. Melcher, Dolan Mj, M T Wong, R Q Warren, Craig W. Hendrix, R N Boswell, S A Anderson, Ronald C. Kennedy, S P Blatt
Publikováno v:
The Journal of infectious diseases. 168(6)
Antibody response to conserved human immunodeficiency virus type 1 (HIV-1)IIIB gp160 epitopes was longitudinally examined in HIV-1-infected persons. Twelve hundred individuals were evaluated, and sequential sera from 25 rapidly progressing (RP) and 3
Publikováno v:
Experimental and clinical immunogenetics. 10(3)
The third variable region (V3) of the HIV-1 gp120 envelope molecule appears to represent a target for naturally occurring neutralizing antibodies in HIV-1-infected individuals. In this report, we examined the extent of antibody cross-reactivity to a
Autor:
W. M. M. M. Nkya, R. R. Redfield, S A Anderson, Gregory P. Melcher, Craig W. Hendrix, R Q Warren, Ronald C. Kennedy, J. F. Shao
Publikováno v:
Journal of virology. 66(9)
Sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals from the United States and Tanzania were examined for antibody reactivity to four synthetic peptides which corresponded to the principal neutralizing determinant from the V3 r
Publikováno v:
Molecular immunology. 29(7-8)
In this report, we assess the humoral immune response in inbred strains of mice immunized with baculovirus-derived recombinant HIV-1 gp160 (rgp160). Six inbred strains of mice were each immunized with two different concns (5 and 50 micrograms) of rgp
Autor:
Ronald C. Kennedy, Craig W. Hendrix, Gregory P. Melcher, Watoky M. M. M. Nkya, John Tesha, Robert R. Redfield, R Q Warren, Patrick Kanda, H Wolf, Donald S. Burke
Publikováno v:
Journal of medical virology. 37(1)
A total of 160 sera from HIV-1 infected individuals from Tanzania were examined for their fine specificity characteristics relative to 9 synthetic peptides that define HIV-1 gp160 epitopes. Immunorecessive and immunodominant epitopes were identified
Autor:
R N Boswell, J. F. Shao, S A Anderson, W. M. M. M. Nkya, M Wabuke, R. R. Redfield, Craig W. Hendrix, Patrick Kanda, H Wolf, R Q Warren
In this study, we compared sera from 159 human immunodeficiency virus type 1 (HIV-1)-infected individuals from Tanzania and 103 infected individuals from the United States for antibodies reactive with 10 HIV-1 gp160 epitopes defined by synthetic pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199a9cc390218ce198cecb4fcfe79e7f
https://europepmc.org/articles/PMC265007/
https://europepmc.org/articles/PMC265007/
Autor:
P. Kanda, K. R. Shuler, R. G. Dunham, R. N. Boswell, R. Q. Warren, R. C. Kennedy, J. Shao, W. M. M. M. Nkya
Publikováno v:
Peptides ISBN: 9789401050050
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02f2e92ed41dfbb3f15ff59b86250465
https://doi.org/10.1007/978-94-011-2264-1_286
https://doi.org/10.1007/978-94-011-2264-1_286
Publikováno v:
Journal of clinical immunology. 11(1)
We examined sera from 160 HIV-infected individuals for antibodies reactive to HIV-1 gp160 epitopes defined by seven synthetic peptides. Seropositive individuals were placed into three groups based upon levels of circulating CD4+ cells. These groups c